Adhibit has criminal doctor Liselotte METTLER, as their principal investigator for their adhesion reducing product.
http://clinicaltrials.gov/ct2/show/NCT00562471
Just like she did with SprayGel....where her science was debunked but at least SprayGel got it's CE mark and is in use despite seeing it fail throughout the patient population.
We can"t believe it.
Um Canada you better pay better attention.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00562471
Locations
Canada, Ontario
St. Joseph's Health Centre
Toronto, Ontario, Canada, M6R 3B2
Germany
Univ. Clinics of Schleswig-Holstein
Kiel, Germany, 24105 ~ Bah haw haw haw!!!
Bethesda Krankenhaus Wupperta
Wuppertal, Germany, 42109
Klinik für Minimal Invasive Chirurgie
Berlin, Germany, 14129
Universitätsklinikum Giessen
Giessen, Germany, D-35385
Netherlands Antilles
St. Elizabeth Hospital
Curaçao, Netherlands AntillesSponsors and Collaborators
Angiotech PharmaceuticalsInvestigators
Principal Investigator:
Liselotte METTLE, MD, PhD
Univ. Clinics of Schleswig-Holstein
More Information
Publications indexed to this study:
Mettler L, Hucke J, Bojahr B, Tinneberg HR, Leyland N, Avelar R. A safety and efficacy study of a resorbable hydrogel for reduction of post-operative adhesions following myomectomy. Hum Reprod. 2008 May;23(5):1093-100. Epub 2008 Mar 17.
Study ID Numbers:
ADH-02-1, ADH-02-1.1, ADH-02-1.2, ADH-02-1.3
First Received:
November 20, 2007
Last Updated:
November 21, 2007
ClinicalTrials.gov Identifier:
NCT00562471
Health Authority:
Germany: Federal Institute for Drugs and Medical Devices; Netherlands: The Central Committee on Research Involving Human Subjects (CCMO); Canada: Health Canada
Keywords provided by Angiotech Pharmaceuticals:
adhesions
gynecologic surgery
laparoscopy
laparotomy
polyethylene glycol
hydrogel
Adhesions following gynecologic surgery to remove myomas
Study placed in the following topic categories:
Neoplasms, Connective and Soft Tissue
Adhesions
Myoma
Additional relevant MeSH terms:
Neoplasms, Muscle Tissue
Neoplasms
Neoplasms by Histologic Type
Pathologic ProcessesClinicalTrials.gov processed this record on July 18, 2008
Angiotech Pharmaceuticals Investigators
Principal Investigator:
Liselotte METTLER, MD, PhD
Ihrt on Mettler:
http://ihrt.blogspot.com/2008/03/liselotte-mettler-prof-dr-med-lies-lies.html#links
http://ihrt.blogspot.com/2008/02/spraygel-in-question.html
http://ihrt.blogspot.com/2008/02/dr-liselotte-mettler-and-her-dangerous.html
http://ihrt.blogspot.com/2008/01/mettlerkruschinski-endogyn-fraud-facts.html
http://ihrt.blogspot.com/2007/12/professor-dr-liselotte-mettler.html
and more......
IHRT is a human rights team of persons from around the world who suffer with ARD. We share a common goal of protecting ourselves and others from practices not wise for persons afflicted with ARD. We address issues surrounding ARD in a public format so that those with ARD are informed in every aspect of an issue so that they can make an informed decisions about health care.
ARD, CAPPS, Adhesions and Adhesion Related Disorder , Internal Scar Tissue, Hope for those who suffer from Adhesions
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment